SCHEMBL7804802

SCHEMBL7804802

CCc1ncnc2ccc(C#Cc3cc(OC)ccc3OC)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 4/20 0.44
MTNR1B P49286 4/20 0.44
DHFR P00374 1/20 0.40
EGFR P00533 7/20 0.40
LCK P06239 2/20 0.40
NPC1 O15118 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
MAPT P10636 1/20 0.38
GRM1 Q13255 1/20 0.38
ALDH1A1 P00352 3/20 0.37
HPGD P15428 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP3A4 P08684 2/20 0.37
CYP2C9 P11712 2/20 0.37
HSD17B10 Q99714 2/20 0.37
CLK4 Q9HAZ1 2/20 0.37
MMP13 P45452 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8434977 0.87 CYP1A2 (0.38) MTNR1AMTNR1BEGFRMAPTALDH1A1
SCHEMBL7802234 0.85 CYP1A2 (0.43) MTNR1AMTNR1BDHFREGFRLCK
SCHEMBL7796228 0.84 CSF1R (0.42) DHFREGFRLCKNPC1NCOA1
SCHEMBL7803054 0.84 DHFR (0.42) DHFREGFRLCKNPC1NCOA1
SCHEMBL7804088 0.81 ALDH1A1 (0.54) EGFRLCKNPC1NCOA1NCOA3
SCHEMBL12844505 0.81 MTNR1B (0.60) MTNR1AMTNR1BEGFRLCKMAPT
SCHEMBL7804835 0.80 EGFR (0.44) EGFRALDH1A1MAPK1CYP1A2CYP3A4
SCHEMBL7802354 0.77 CSF1R (0.42) MTNR1AMTNR1BDHFREGFRLCK
SCHEMBL4933784 0.77 MTNR1A (0.47) MTNR1AMTNR1BDHFREGFRLCK
SCHEMBL7804549 0.76 EGFR (0.51) EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0815087-B1 TRISUBSTITUTED PHENYL DERIVATIVES NOVARTIS AG (CH) 2001-11-14 EP disclosed
US-5990116-A USE IN PREVENTION OR TREATMENT OF INFLAMMATORY AND PROLIFERATIVE SKIN DISEASES AND CANCER; COMPOUNDS SUCH AS 6-(2-(2,5-DIMETHOXYPHENYL)ETHYL)-4-ETHYL-QUINAZOLINE NOVARTIS AG (CH) 1999-11-23 US disclosed
EP-0815087-A1 TRISUBSTITUTED PHENYL DERIVATIVES Novartis AG (CH) 1998-01-07 EP disclosed
WO-1996028430-A1 TRISUBSTITUTED PHENYL DERIVATIVES NOVARTIS AG (CH) 1996-09-19 WO disclosed